Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...